Outcomes of second allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia

BACKGROUND: Relapse after allogeneic hematopoietic cell transplantation (HCT) leads to poor survival in patients with acute myeloid leukemia (AML). A second HCT (HCT2) may achieve durable remission. OBJECTIVES: To determine the outcomes of patients who received an HCT2 for relapsed AML and to evalua...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Transplant Cell Ther
Autores principales: Yalniz, Fevzi F., Saliba, Rima M., Greenbaum, Uri, Ramdial, Jeremy, Popat, Uday, Oran, Betul, Alousi, Amin, Olson, Amanda, Alatrash, Gheath, Marin, David, Rezvani, Katy, Hosing, Chitra, Im, Jin, Mehta, Rohtesh, Qazilbash, Muzaffar, Joseph, Jacinth Joy, Rondon, Gabriela, Kanagal-Shamanna, Rashmi, Shpall, Elizabeth, Champlin, Richard, Kebriaei, Partow
Formato: Artigo
Lenguaje:Inglês
Publicado: 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8316329/
https://ncbi.nlm.nih.gov/pubmed/34023569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtct.2021.05.007
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares